The Petri Dish: Sage, Biogen plan drug application; TV show gets FDA nod

While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of Greater Boston life sciences and health care happenings. $2.8M for antibiotic resistance Selux Diagnostics, a Boston-based startup focused on antibiotic-resistant diseases, received $2.8 million from the National Institutes…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news